Nihon Kohden (NHNKY) Expected to Announce Earnings on Tuesday

Nihon Kohden (OTCMKTS:NHNKY) will likely be releasing its results after the market closes on Tuesday, November 10th. Analysts expect the company to post earnings of $0.17 per share and revenue of $352.12 million for the quarter.

Nihon Kohden (OTCMKTS:NHNKY) last announced its earnings results on Thursday, August 6th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.06 by ($0.09). The firm had revenue of $297.47 million during the quarter, compared to analyst estimates of $299.98 million. Nihon Kohden had a return on equity of 9.17% and a net margin of 5.90%. On average, analysts expect Nihon Kohden to post $0.60 EPS for the current fiscal year and $0.66 EPS for the next fiscal year.

Nihon Kohden Trading Down 1.0%

Shares of Nihon Kohden stock traded down $0.10 during trading on Tuesday, hitting $10.06. The stock had a trading volume of 212 shares, compared to its average volume of 22,260. The stock has a 50 day simple moving average of $10.00 and a 200 day simple moving average of $9.82. The company has a market capitalization of $1.69 billion, a PE ratio of 18.29 and a beta of 0.38. The company has a quick ratio of 2.64, a current ratio of 3.98 and a debt-to-equity ratio of 0.12. Nihon Kohden has a 1 year low of $8.12 and a 1 year high of $13.61.

Analyst Ratings Changes

Separately, UBS Group downgraded shares of Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 12th. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Nihon Kohden currently has an average rating of “Hold”.

About Nihon Kohden

Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and markets electronic medical equipment and related solutions. Founded in 1951 and headquartered in Tokyo, the company serves hospitals, clinics and other healthcare providers through operations in Japan and international markets.

Its product portfolio includes patient monitoring systems, electrocardiographs, electroencephalographs and other neurological diagnostic equipment. Nihon Kohden also supplies defibrillators, automated external defibrillators, ventilators, anesthesia-related equipment, clinical information systems and devices used in in-vitro diagnostics, including hematology testing.

The company distributes its products through domestic and overseas subsidiaries, distributors and service networks.